Engrail Therapeutics

0 followers


Transforming the lives of patients with life-limiting diseases of the nervous system. Acquiring, developing and commercializing transformative medicines.

Employees

11-50

Links

Org chart

Vikram Sudarsan
President, CEO & Board Member

Vikram Sudarsan

Collapse
Rex E. Bosen
Acting CFO
Stephen Cunningham
Chief Development Officer & Board Member
Kimberly Vanover
Chief Scientific Officer
Camilla Gomiero
VP, Commercial Strategy
Rasesh Shah
Senior Director, Program Management
Krishna Vadodaria
Associate Director, Neurobiology
Neil Mhaskar
VP, Drug Development & Manufacturing
Anil Vootkur
VP, Corporate Development
Eve Taylor
VP, Clinical Development
Bill Brubaker
Senior Vice President of Nonclinical Development, Head of Pharmacokinetics and Drug Metabolism
Eve M. Taylor, PhD
Senior Vice President, Clinical Development
Penelope Przekop
Data Protection Officer | Executive QA Consultant
Paul Cayer
Chief Financial Officer